Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Lederman

Showing results (261-270 of 303) with videos related to

Pageof 31
Sort By:
Pathogens & Immunity|September 27, 2016
A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"?Michael M Lederman, Paula M Cannon, Judith S Currier, et al.
The Lancet. HIV|September 15, 2015
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS StudyJuan G Sierra-Madero, Susan Ellenberg, Mohammed S Rassool, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2011
No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapyRajesh T Gandhi, Robert W Coombs, Ellen S Chan, et al.
Nature Medicine|March 12, 2013
Inadequate T follicular cell help impairs B cell immunity during HIV infectionRafael A Cubas, Joseph C Mudd, Anne-Laure Savoye, et al.
Plos Pathogens|February 6, 2014
Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administrationIrini Sereti, Jacob D Estes, William L Thompson, et al.
Structural Heart : the Journal of the Heart Team|July 31, 2023
Platelet and Monocyte Activation After Transcatheter Aortic Valve Replacement (POTENT-TAVR): A Mechanistic Randomized Trial of Ticagrelor Versus ClopidogrelDavid A Zidar, Sadeer Al-Kindi, Chris T Longenecker, et al.
Blood|April 17, 2013
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trialPeter W Hunt, Nancy S Shulman, Timothy L Hayes, et al.
The Journal of Infectious Diseases|June 7, 2003
Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumesRobert C Kalayjian, Alan Landay, Richard B Pollard, et al.
The Lancet. HIV|October 2, 2015
Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trialJuan G Sierra-Madero, Susan S Ellenberg, Mohammed S Rassool, et al.
AIDS Research and Human Retroviruses|March 4, 2016
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1Jeffrey M Jacobson, Steven E Bosinger, Minhee Kang, et al.
Pageof 31

Showing results (261-270 of 303) with videos related to

Sort By:
Pageof 31
Pathogens & Immunity|September 27, 2016
A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"?Michael M Lederman, Paula M Cannon, Judith S Currier, et al.
The Lancet. HIV|September 15, 2015
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial of a Chemokine Receptor 5 (CCR5) Antagonist to Decrease the Occurrence of Immune Reconstitution Inflammatory Syndrome in HIV-Infection: The CADIRIS StudyJuan G Sierra-Madero, Susan Ellenberg, Mohammed S Rassool, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 16, 2011
No effect of raltegravir intensification on viral replication markers in the blood of HIV-1-infected patients receiving antiretroviral therapyRajesh T Gandhi, Robert W Coombs, Ellen S Chan, et al.
Nature Medicine|March 12, 2013
Inadequate T follicular cell help impairs B cell immunity during HIV infectionRafael A Cubas, Joseph C Mudd, Anne-Laure Savoye, et al.
Plos Pathogens|February 6, 2014
Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administrationIrini Sereti, Jacob D Estes, William L Thompson, et al.
Structural Heart : the Journal of the Heart Team|July 31, 2023
Platelet and Monocyte Activation After Transcatheter Aortic Valve Replacement (POTENT-TAVR): A Mechanistic Randomized Trial of Ticagrelor Versus ClopidogrelDavid A Zidar, Sadeer Al-Kindi, Chris T Longenecker, et al.
Blood|April 17, 2013
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trialPeter W Hunt, Nancy S Shulman, Timothy L Hayes, et al.
The Journal of Infectious Diseases|June 7, 2003
Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumesRobert C Kalayjian, Alan Landay, Richard B Pollard, et al.
The Lancet. HIV|October 2, 2015
Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): a double-blind, randomised, placebo-controlled trialJuan G Sierra-Madero, Susan S Ellenberg, Mohammed S Rassool, et al.
AIDS Research and Human Retroviruses|March 4, 2016
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1Jeffrey M Jacobson, Steven E Bosinger, Minhee Kang, et al.
Pageof 31